PREVEST DENPRO
|
PREVEST DENPRO Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.09 | 9.64 | 252.87 | 1,757.44 | 1,050.46 |
| CEPS(Rs) | 13.65 | 10.07 | 8.69 | 6.17 | 3.85 |
| DPS(Rs) | 1.00 | - | - | - | - |
| Book NAV/Share(Rs) | 60.65 | 47.56 | 789.33 | 5,370.49 | 3,613.05 |
| Tax Rate(%) | 25.04 | 27.93 | 22.80 | 20.21 | 20.30 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 39.03 | 38.67 | 31.10 | 22.31 | 19.43 |
| EBIT Margin(%) | 41.70 | 41.46 | 33.05 | 28.12 | 19.88 |
| Pre Tax Margin(%) | 41.29 | 40.77 | 32.18 | 26.98 | 18.84 |
| PAT Margin (%) | 30.95 | 29.39 | 24.84 | 21.53 | 15.02 |
| Cash Profit Margin (%) | 32.28 | 30.72 | 26.47 | 23.42 | 17.04 |
| Performance Ratios | |||||
| ROA(%) | 22.01 | 24.40 | 27.85 | 27.50 | 22.30 |
| ROE(%) | 24.19 | 29.07 | 38.13 | 39.13 | 34.02 |
| ROCE(%) | 32.25 | 39.64 | 46.96 | 45.63 | 39.27 |
| Asset Turnover(x) | 0.71 | 0.83 | 1.12 | 1.28 | 1.49 |
| Sales/Fixed Asset(x) | 4.43 | 3.98 | 3.36 | 2.90 | 2.83 |
| Working Capital/Sales(x) | 1.04 | 0.83 | 1.70 | 1.98 | 2.99 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.23 | 0.25 | 0.30 | 0.35 | 0.35 |
| Receivable days | 23.82 | 28.13 | 37.14 | 36.13 | 36.55 |
| Inventory Days | 28.96 | 21.03 | 15.12 | 12.78 | 9.03 |
| Payable days | 44.34 | 104.63 | 122.26 | 68.67 | 64.28 |
| Valuation Parameters | |||||
| PER(x) | 21.25 | 37.45 | - | - | - |
| PCE(x) | 20.38 | 35.83 | - | - | - |
| Price/Book(x) | 4.59 | 7.59 | - | - | - |
| Yield(%) | 0.36 | - | - | - | - |
| EV/Net Sales(x) | 5.91 | 10.29 | -0.52 | -0.37 | -0.23 |
| EV/Core EBITDA(x) | 13.50 | 23.29 | -1.47 | -1.20 | -1.00 |
| EV/EBIT(x) | 13.93 | 24.04 | -1.54 | -1.28 | -1.10 |
| EV/CE(x) | 3.75 | 6.12 | -0.48 | -0.40 | -0.28 |
| M Cap / Sales | 6.70 | 11.37 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 30.81 | 33.84 | 25.06 | 18.12 | 13.53 |
| Core EBITDA Growth(%) | 29.65 | 67.43 | 44.15 | 59.83 | 22.61 |
| EBIT Growth(%) | 29.68 | 70.21 | 46.61 | 65.02 | 25.97 |
| PAT Growth(%) | 35.80 | 60.53 | 43.88 | 67.30 | 37.92 |
| EPS Growth(%) | 35.80 | -96.19 | 43.88 | 67.30 | 37.92 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.02 | 0.06 | 0.11 | 0.14 |
| Current Ratio(x) | 9.98 | 9.76 | 3.61 | 4.08 | 3.00 |
| Quick Ratio(x) | 9.10 | 9.16 | 3.41 | 3.78 | 2.85 |
| Interest Cover(x) | 100.94 | 60.34 | 37.69 | 24.80 | 19.10 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of PREVEST DENPRO
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PREVEST DENPRO | ₹491.9 Cr | -6.1% | 21.7% | 25.5% | Stock Analytics | |
| POLY MEDICURE | ₹15,747.5 Cr | 5.4% | 3.6% | 69.4% | Stock Analytics | |
| NURECA | ₹288.6 Cr | -1.6% | 6.9% | -15.1% | Stock Analytics | |
PREVEST DENPRO Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PREVEST DENPRO | -6.1% |
21.7% |
25.5% |
| SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses
